AJANTPHARM.BOAJANTPHARM.BOBSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank29
5Y CAGR-4.4%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
-4.4%/yr
Long-term compound
Percentile
P29
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202515.04%
2024176.73%
2023-9.02%
2022-9.51%
202146.96%
202018.83%
2019-18.54%
2018-9.02%
201723.00%
201619.61%